−1.54
NeuroSense Therapeutics Ltd.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−7.62
FY23:
−8.35
FY24:
−10.1
FY25:
−7.67
Change from FY21 to FY25
millions USD
FY21:
−0.02
FY22:
−3.59
FY23:
3.47
FY24:
0.00
FY25:
−0.01
Change from FY21 to FY25
millions USD
FY21:
11.9
FY22:
3.77
FY23:
3.98
FY24:
10.9
FY25:
4.43
(positive)
Change from FY21 to FY25
millions USD
FY21:
−1.56
FY22:
−7.69
FY23:
−8.38
FY24:
−10.1
FY25:
−7.68
All amounts in millions USD